MHA FPX 5014 Assessment 3 Risk Control and Compliance Program Proposal example

Reviewed by Rupert Danvers, MBA Healthcare Quality, Risk, and Regulatory Compliance Capella University Free custom sample in 24 to 48h

This MHA FPX 5014 Assessment 3 sample paper proposes a risk control plan for insulin-related hypoglycemia, with controls, named accountability, costed staff time and an honest statement of the risk that remains. It closes Capella MHA FPX 5014, the MHA quality, risk and compliance course with the catalog code MHA-FPX5014. The proposal identifies the causes, sets out controls rather than commitments, each saying what it prevents or detects and what record it leaves, and names accountability by role. It measures results against the original rate, costs the staff time the controls require and accepts residual risk openly rather than promising zero harm.

CourseMHA FPX 5014 Healthcare Quality, Risk, and Regulatory Compliance
AssessmentAssessment 3
Paper typeRisk control and compliance plan
LengthAbout 1,080 words, 5 pages
FormatAPA 7 student paper
SchoolCapella University
ProgramMaster of Health Administration (MHA)
UpdatedSeptember 2026

Free sample paper for MHA FPX 5014 Assessment 3

1

A Risk Control Plan for Insulin-Related Hypoglycemia: Controls, Named Accountability, Costed Staff Time, and the Risk That Remains

Student Name

Capella University

MHA FPX 5014: Healthcare Quality, Risk, and Regulatory Compliance

Instructor Name

Month Day, Year

What this part is doingThe title names the risk and the four features of the plan. A risk control plan is judged on whether it would actually change practice, so controls lead.
2

Introduction

Insulin is one of the medications most often involved in serious harm in hospitals, because small errors in dose or timing can cause dangerously low blood glucose. At a composite 190-bed community hospital, here called Westbrook Hospital, a review of glucose data for the past year found 312 readings under 70 mg/dL, each counted as a hypoglycemic episode, among patients receiving insulin on the medical-surgical units, across 6,500 patient days on insulin. That is a rate of 4.8 hypoglycemic episodes per 100 insulin patient days. Nineteen episodes fell below 40 mg/dL, and two patients required transfer to intensive care. This paper sets out a plan to reduce that rate.

The Causes Identified

A review of 60 episodes by a pharmacist, a diabetes nurse educator, and a hospitalist found four main causes. In 22 episodes, rapid-acting insulin was given when the patient's meal was delayed or not eaten. In 14, the patient was receiving only sliding-scale insulin, which reacts to high readings rather than preventing them and often leads to swings between high and low values. In 11, the patient's kidney function had worsened, reducing insulin clearance, without a dose adjustment. In 8, basal insulin was continued at the home dose while the patient was eating much less than at home. The remaining episodes had mixed causes.

Controls, Not Commitments

A commitment is a promise to be more careful. A control is a change in the system that makes the error harder to make or easier to catch. The plan relies on five controls. First, a standardized insulin order set in the electronic record. The order set defaults to scheduled basal and mealtime insulin with a correction dose, rather than sliding scale alone, and requires the prescriber to enter the patient's weight and kidney function. Umpierrez et al. (2007), in a randomized trial of patients with type 2 diabetes on general medical wards, found that a basal-bolus regimen produced better glucose control than sliding-scale insulin alone, without a significant increase in hypoglycemia. Second, a nurse-driven hypoglycemia protocol ordered automatically with any insulin order, so that nurses can treat low glucose immediately without waiting to reach a prescriber. Third, a hold rule for mealtime insulin: nurses give rapid-acting insulin only once the meal tray is present and the patient has started eating, with the dose reduced by half if the patient eats less than half the meal. The electronic record will display the rule at the time of administration. Fourth, an automatic alert to the pharmacist when a patient on insulin has a creatinine rise of 50% or more, prompting review of the dose. Fifth, a daily pharmacist review of every patient with any glucose reading below 70 mg/dL in the previous 24 hours, with a recommended dose change sent to the prescriber. Each control acts on a cause found in the review, so the plan can be traced from the problem to the fix.

What this part is doingThe controls are system changes tied to specific causes. Scorers reward risk plans that rely on design rather than on staff being more careful.
3

Accountability Named by Role

Each control has an owner by role. The chief medical informatics officer owns the order set and the administration display, including building, testing, and maintaining them. The director of pharmacy owns the kidney function alert and the daily pharmacist review. The chief nursing officer owns the hypoglycemia protocol and the meal-timing rule, including training and audit. The hospitalist medical director owns physician adoption of the order set and reviews prescribers who bypass it. The patient safety officer owns measurement and reports results monthly to the quality committee. Naming roles rather than individuals keeps accountability in place when people change jobs, and it tells staff exactly whom to call when a control fails.

Measured Against the Original Rate

Success is measured against the baseline of 4.8 episodes below 70 mg/dL per 100 insulin patient days. The target is 3.0 within 12 months, a reduction of about 38%. Severe episodes, below 40 mg/dL, are tracked separately, with a target of fewer than 8 a year, compared with 19. The patient safety officer will also track two process measures: the share of insulin orders placed through the order set, with a target of 90%, and the share of mealtime doses given with the meal, measured by monthly audit of 30 administrations. Tracking process measures shows whether the controls are in use before the outcome rate has time to change.

What this part is doingTargets are stated against the baseline and include both outcome and process measures. Measuring against the original rate makes the plan's effect visible.
4

Staff Time Costed

The plan's cost is mostly staff time. Building and testing the order set and alerts will take about 120 hours of informatics analyst time, about 7,800 dollars. The daily pharmacist review is expected to involve about 5 patients a day at 10 minutes each, or about 300 hours of pharmacist time a year, about 21,000 dollars. Training 240 nurses for 30 minutes and 45 prescribers for 20 minutes adds about 135 hours, about 7,000 dollars. The meal-timing rule adds a few seconds to each administration but no measurable time overall. The total first-year cost is about 36,000 dollars. For comparison, the two intensive care transfers last year alone added about 18,000 dollars in costs the hospital could not bill, and severe hypoglycemia carries a risk of injury and longer stays.

Residual Risk Accepted Openly

Some risk will remain. Patients whose eating changes suddenly, such as those made nothing by mouth for an unplanned procedure after receiving basal insulin, will still be at risk. Patients with rapidly changing kidney function may experience hypoglycemia before the alert and review can act. Prescribers can bypass the order set in urgent situations. Umpierrez et al. (2007) reported that hypoglycemia still occurred with basal-bolus therapy, so the order set reduces risk rather than eliminating it. Stating the risk that remains, and accepting it deliberately, is more honest than implying that a plan will prevent every event. The quality committee is asked to accept this residual risk and to review every severe episode individually, so that each one is used to test whether a further control is needed.

Conclusion

Westbrook's plan addresses the causes of insulin-related hypoglycemia with five controls, each owned by a named role. Results will be measured against the original rate of 4.8 episodes per 100 insulin patient days, the staff time is costed at about 36,000 dollars in the first year, and the remaining risk is stated and accepted openly.

5

References

Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007). Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care, 30(9), 2181-2186. https://doi.org/10.2337/dc07-0295

What the MHA FPX 5014 Assessment 3 instructions ask for

To close the course, you design a compliance or risk control program around one quality or safety problem. You state the program's objective, design controls that prevent or detect the problem, assign accountability for operating, monitoring and reporting each control, set measures against a baseline, estimate costs including staff time and state the residual risk. Controls are mechanisms that leave a record, not policies or intentions. The program should connect to the diagnosis and regulatory review from earlier assessments. Scholarly sources and safety organization guidance, such as ISMP recommendations for insulin, support the controls. The plan should read as something a compliance committee could approve.

How this MHA FPX 5014 Assessment 3 example is built

Objective, controls, accountability, measurement. The opening states what the program is for, tied to the diagnosed problem and the obligations reviewed. A controls block sets out each mechanism, saying what it prevents or detects and what record it leaves. An accountability block names roles: who operates each control, who monitors, who reports upward and at what frequency. A measurement block returns to the original rate and states the target, the interval and what result would trigger escalation. A resource block states the staff time required and where it comes from. A sustainability block covers what keeps the program running once the attention moves on. The closing names the residual risk the program accepts. Regulatory claims carry citations. Each control is mapped to the obligation it satisfies, since that crosswalk is what a surveyor effectively asks for.

Where the marks sit in the MHA FPX 5014 Assessment 3 scoring guide

The scoring guide rates the objective, the controls, the accountability, the measurement, the cost and the residual risk. Controls reach Distinguished when each is a mechanism, such as a hard stop in the order set or a pharmacist review, with the record it leaves. Accountability scores higher when roles are named for operating, monitoring and reporting each control. Measurement earns credit when results are compared with the original hypoglycemia rate and reported on a set schedule. Costing staff time shows realism, since every control consumes pharmacist or nurse hours. Stating residual risk honestly shows maturity. Mapping controls to the regulatory obligations from Assessment 2 shows integration across the course. Writing and APA are graded too, and a control table with columns for mechanism, owner and record keeps the plan auditable.

MHA FPX 5014 Assessment 3 help from the desk

Students often propose policies and education as controls, which leave no record and are hard to audit. Another common mistake is assigning accountability to departments rather than roles, so no individual answers for a failed control. Measures are not tied to the original baseline, so progress cannot be judged. Staff time is ignored, which makes the plan look free when it is not. Residual risk is left unstated, implying the problem will disappear. Controls are not linked to the obligations reviewed earlier. Too many controls can overload staff and lead to workarounds. The strongest plans are short, specific and auditable, with a review date for each control.

Get a MHA FPX 5014 Assessment 3 example written to your instructions

Send the Assessment 3 instructions and the MHA FPX 5014 scoring guide from your courseroom, with the diagnosis and regulatory review your earlier assessments produced. We write a custom example against those exact criteria and return it in 24 to 48 hours. The first custom sample is free, and mapping each control to the obligation it satisfies is what makes a programme defensible. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.

More MHA FPX 5014 papers and MHA samples

MHA FPX 5014 Assessment 3 questions, answered

What is the difference between a control and a policy?

A policy says what should happen; a control makes it happen or detects when it did not. A rule requiring two signatures is a policy, and a system that will not release the order without them is a control. Programs made entirely of policies fail at survey because nothing produces evidence.

How do I map controls to requirements?

Build a simple crosswalk: this obligation, from this authority, is satisfied by this control, evidenced by this record. Surveyors effectively ask that question, and an organization that has already answered it in writing is in a far stronger position than one reconstructing the mapping under pressure.

Why does staff time matter in a compliance proposal?

Because compliance work competes with clinical and operational work and usually loses. A program requiring hours nobody has will be performed briefly and then quietly dropped, which is worse than not starting it. Naming the cost and saying where it comes from is what makes the proposal survivable.

Where can I find a free MHA FPX 5014 Assessment 3 sample paper?

This page holds the full insulin hypoglycemia control plan, with causes, controls, named roles, measurement, costed time and residual risk. A custom plan for your problem can be written at no charge.

What is the difference between a control and a policy in MHA FPX 5014 Assessment 3?

A policy states what should happen; a control is a mechanism that makes it happen or detects when it does not, and leaves a record, such as an order set hard stop or an audit report.